PLSH.US Panacea Life Sciences Holdings Inc
- Market cap
- USD 4.92M
- P/E
- -
- P/B
- 0.47x
- ROE
- 42.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2025.
Is PLSH.US undervalued?
Graham numberThe Graham number of Panacea Life Sciences Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Panacea Life Sciences Holdings Inc fundamental analysis
No fundamental analysis for Panacea Life Sciences Holdings Inc yet.
Panacea Life Sciences Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and wellness. The company also offers natural remedies under the PANA Health, PANA …
Full company profilePanacea Life Sciences Holdings Inc financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Panacea Life Sciences Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 346K | 2.07M | 2.06M | 1.63M | 2.38M | 530K |
| Gross Profit | - | - | -1.70M | -649K | 541K | 396K | 1.12M | 461K |
| Operating Income | -2.07M | -2.44M | -10.9M | -5.98M | -5.54M | -5.65M | -5.55M | -1.77M |
| EBITDA | -3.79M | -3.87M | -8.85M | -9.00M | -2.71M | -5.36M | -4.75M | 2.75M |
| Net Income | -3.86M | -4.34M | -9.69M | -9.46M | -4.78M | -9.14M | -8.02M | 1.58M |
| EPS | -25 | -19 | -6.19 | -4.70 | -0.32 | -0.61 | -0.45 | 0.07 |
| Balance Sheet | ||||||||
| Total Assets | 173K | 14.3K | 9.80M | 71.3K | 23.8M | 19.5M | 18.0M | 3.98M |
| Total Liabilities | 2.39M | 3.44M | 6.12M | 5.11M | 16.7M | 21.6M | 26.3M | 234K |
| Shareholders' Equity | -2.22M | -3.42M | 3.68M | -5.04M | 7.10M | -2.14M | -8.29M | 3.75M |
| Cash & Short-term Investments | 161K | 1.96K | 18.4K | 25.1K | 19.8K | 6.95K | 101K | 8.36K |
| Cash Flow | ||||||||
| Operating Cash Flow | -1.23M | -466K | -3.89M | -7.65M | -3.92M | -2.40M | -1.52M | -3.90M |
| Capital Expenditure | 0.00 | 0.00 | 6.98M | 3.20M | 163K | 244K | 65.3K | 0.00 |
| Free Cash Flow | -1.23M | -466K | -6.29M | -692K | -3.92M | -2.64M | -1.59M | -3.90M |
| Ratios | ||||||||
| ROE | - | - | -263.1% | - | -67.3% | - | - | 42.1% |
| ROA | -2,235.8% | -30,352.1% | -98.9% | -13,274.8% | -20.1% | -46.9% | -44.6% | 39.6% |
| Net Profit Margin | - | - | -2,802.3% | -456.8% | -232.2% | -561.9% | -336.1% | 298.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Panacea Life Sciences Holdings Inc dividends
Panacea Life Sciences Holdings Inc has not paid dividends in the last 7 fiscal years.
Last stock split: 1:28 on Oct 28, 2021.
Who owns Panacea Life Sciences Holdings Inc
- Insiders 47.73%
- Institutions 0.00%
- Public & others 52.27%
- Shares outstanding 59.5M
- Free float 12.5M
Panacea Life Sciences Holdings Inc company profile
- Company name
- Panacea Life Sciences Holdings Inc
- Ticker
- PLSH.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 40
- Fiscal year end
- December
- Address
- 5910 South University Boulevard, Greenwood Village, CO, United States, 80121
- Phone
- 303 434 0215
- Website
- panacealife.com
About Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and wellness. The company also offers natural remedies under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand names. It manages retail locations and a distribution center in the Tampa, Florida. The company was incorporated in 2008 and is based in Greenwood Village, Colorado.
Panacea Life Sciences Holdings Inc management
2- Ms. Leslie A. ButtorffChairman, CEO & CFO · born 1958
- Mr. Nathan Joel BermanSecretary & Principal Accounting Officer · born 1987